Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
05/08/1990 | CA1268898A1 Growth hormone-releasing peptides and method of treating mammals therewith |
05/08/1990 | CA1268897A1 Gonadoliberin derivatives and process for the preparation thereof |
05/08/1990 | CA1268711A1 Composition for alleviating cystic fibrosis |
05/07/1990 | CA2002352A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
05/07/1990 | CA2002261A1 High molecular weight human angiogenic factors |
05/03/1990 | WO1990004788A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
05/03/1990 | WO1990004642A1 Method for isolating glycosylated interleukine-2 and glycosylated interleukine-2 |
05/03/1990 | WO1990004641A1 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS) |
05/03/1990 | WO1990004635A1 Thrombolytic agents with modified kringle domains |
05/03/1990 | WO1990004634A1 Monoclonal antibodies against receptor-induced binding sites |
05/03/1990 | WO1990004606A1 A process for fractionating polyethylene glycol (peg)-protein adducts and an adduct of peg and granulocyte-macrophage colony stimulating factor |
05/03/1990 | WO1990004605A1 Calcitonin gene related peptide analogues |
05/03/1990 | WO1990004417A1 Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis |
05/03/1990 | WO1990004415A1 Anti-idiotypic antibody induction of antitumor response |
05/03/1990 | WO1990004414A1 Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection |
05/03/1990 | WO1990004413A1 ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED Fc REGIONS |
05/03/1990 | WO1990004412A1 Liposome immunoadjuvants containing il-2 |
05/03/1990 | WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment |
05/03/1990 | WO1990004409A1 Human leukocyte elastase inhibitors and methods of producing and using same |
05/03/1990 | WO1990004408A1 Composition and treatment with biologically active peptides and certain anions |
05/03/1990 | WO1990004407A1 Cpf peptide compositions and uses |
05/03/1990 | WO1990004406A1 Drug containing a glycosylated interleukine-2 |
05/03/1990 | WO1990004405A1 Antiviral agent |
05/03/1990 | WO1990004404A1 Gynaecological procedure |
05/03/1990 | WO1990004392A1 Method to improve survival of patients during sepsis by diet composition |
05/03/1990 | WO1990004388A1 In vivo neurotrophic cytoprotective alcohols |
05/03/1990 | WO1990004386A1 Orally pharmaceutical preparations with colon selective delivery |
05/03/1990 | WO1990003181A3 Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product |
05/03/1990 | DE3935517A1 Ophthalmische zubereitungen enthaltend ein cyclosporin Ophthalmic preparations containing a cyclosporin |
05/02/1990 | EP0366638A2 Neuromodulatory peptide |
05/02/1990 | EP0366621A1 Orally pharmaceutical preparations with colon selective delivery |
05/02/1990 | EP0366532A1 Medical preparations containing glycosylated interleukin-2 |
05/02/1990 | EP0366397A1 Novel bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
05/02/1990 | EP0366277A2 Pharmaceutical formulations |
05/02/1990 | EP0366091A2 Muteins of a tissue plasminogen activator with duplicated domains |
05/02/1990 | EP0366043A1 Monoclonal antibody |
05/02/1990 | EP0366033A2 Method of improving post-ischemic myocardial dysfunction using an ace inhibitor alone or in combination with a thrombolytic agent and combination |
05/02/1990 | EP0366016A2 Endothelin DNA and use thereof |
05/02/1990 | EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment |
05/02/1990 | EP0365992A1 Heterocyclic peptide renin inhibitors |
05/02/1990 | EP0365956A2 Carcinostatic agents |
05/02/1990 | EP0365837A2 Intercellular adhesion molecules, and their binding ligands |
05/02/1990 | EP0365779A2 Cyclic GRF-analogs II |
05/02/1990 | EP0365705A1 Biopreparation for the treatment of wounds |
05/02/1990 | EP0365704A1 Biopreparation for the hemostasis in stomach bleedings |
05/02/1990 | EP0365657A1 Dna encoding androgen receptor protein |
05/02/1990 | EP0365656A1 Prophylactic and therapeutic methods for treating edema with phallotoxins |
05/02/1990 | EP0365643A1 Compounds for diagnosis and/or therapy of tumours |
05/02/1990 | EP0365568A1 Proteins and derivatives thereof |
05/02/1990 | EP0197149B1 Method of obtaining human leukocytic interferon |
05/02/1990 | CA2002130A1 Method for the treatment of periodontal disease |
05/01/1990 | US4921841 Immunoaffinity purification of phytolaccin proteins and their use in treating Herpes Simplex virus type II |
05/01/1990 | US4921837 Treatment of AIDS-type disease |
05/01/1990 | US4921835 Method of treating asthma |
05/01/1990 | US4921710 Method of converting cholesterol in food to coprostanol |
05/01/1990 | US4921699 Polypeptides having interferon activity |
05/01/1990 | US4921698 Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4 |
05/01/1990 | US4921697 IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone |
05/01/1990 | US4921667 Method for augmenting immune response |
05/01/1990 | CA2001897A1 Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin |
05/01/1990 | CA2001884A1 Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon |
05/01/1990 | CA2000887A1 Thromboresistant materials and methods for making same |
05/01/1990 | CA1268597A1 Diamino acid derivatives |
05/01/1990 | CA1268417A1 Intragonadal regulatory protein |
04/30/1990 | CA2001911A1 Albumin preparation and process for preparing the same |
04/30/1990 | CA2001787A1 Modified interleukin-2 and production thereof |
04/30/1990 | CA2001771A1 Sequence specific gene repressor |
04/29/1990 | CA2000717A1 Process for producing hemoglobin concentrate |
04/28/1990 | CA2345497A1 Growth hormone variants and method for forming growth hormone variants |
04/27/1990 | CA2001629A1 Human leukocyte elastase inhibitors and methods of producing and using same |
04/27/1990 | CA2001498A1 Neuromodulatory peptide |
04/27/1990 | CA2001494A1 Carcinostatic agents |
04/27/1990 | CA2001343A1 Thrombolytic agents with modified kringle domains |
04/26/1990 | CA2001502A1 Cyclosporin ophthalmic compositions |
04/26/1990 | CA2001292A1 Isolation and cloning of complementary dna for gene coding of bovine trophoblast protein-1 |
04/25/1990 | EP0365468A1 Pharmaceutically active combination comprising a plasminogen activator and hirudin |
04/25/1990 | EP0365319A2 Glycopeptide antibiotics |
04/25/1990 | EP0365134A1 Synergistic compositions of renal dopaminergic agent and angiotensin converting enzyme inhibitors |
04/25/1990 | EP0365045A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use |
04/25/1990 | EP0365044A2 Novel pharmaceutical use of (NVA)2-cyclosporine |
04/25/1990 | EP0364980A2 Colony stimulating factor-gelatin conjugate |
04/25/1990 | EP0364942A2 Isohirudine |
04/25/1990 | EP0364819A2 LHRH analogs |
04/25/1990 | EP0364690A2 The alpha-subunit of the Mac-1 leukocyte adhesion receptor |
04/25/1990 | EP0364561A1 FACTOR VII/VIIa ACTIVE SITE INHIBITORS |
04/25/1990 | EP0364509A1 Cellular toxic conjugates |
04/25/1990 | EP0364493A1 Renin inhibiting peptides with nonpeptide linkages |
04/25/1990 | EP0364491A1 Stabilized formulations of gamma interferons |
04/25/1990 | EP0364481A1 Growth factors |
04/25/1990 | EP0163723B1 Ddavp antidiuretic and method therefor |
04/25/1990 | CA2001333A1 Gynaecological procedure |
04/24/1990 | US4920196 Human lymphotoxin |
04/24/1990 | US4920194 Blood substitute |
04/24/1990 | US4920144 Derivatives of bicyclic amino acids, agents containing them and their use as hypotensives |
04/24/1990 | US4919927 Using ammonium chloride |
04/24/1990 | US4919917 Administering organogermanium compound |
04/24/1990 | CA2001373A1 Methods and compositions for diagnosing, monitoring and treating the early stage of osteoarthritis |
04/24/1990 | CA2000469A1 Method of improving post-ischemic myocardial dysfunction using and ace inhibitor alone or in combination with a thrombolytic agent and combination |
04/24/1990 | CA1268300A1 Method of somatotropin solubilization and naturation |
04/21/1990 | CA2001150A1 Composition and treament with biologically active peptides and certain anions |